Skip to main content
Year archive

TME Pharma N.V. — 2026 filings

All 8 regulatory filings released by TME Pharma N.V. (ALTME) in 2026, sourced directly from the official regulator.

8 Filings
2026 Period
2026 filings (8)
Filing Released Lang
TME PHARMA PUBLIE SES RÉSULTATS FINANCIERS ANNUELS ET SON RAPPORT ANNUEL
Regulatory Filings
2026-04-30 French
TME Pharma publishes its annual financial results and annual report
Regulatory Filings
2026-04-30 English
TME PHARMA ANNONCE LA PUBLICATION DANS *NATURE COMMUNICATIONS* DES RÉSULTATS DE L'ESSAI GLORIA CONCERNANT LE VOLET D'EXTENSION A DE PHASE 1/2 DE LA « TRIPLE THÉRAPIE » NOX-A12
Regulatory Filings
2026-04-16 French
TME Pharma Announces Publication of NOX-A12 “Triple Therapy” Phase 1/2 Expansion Arm A Findings from GLORIA trial in Nature Communications
Regulatory Filings
2026-04-16 English
TME PHARMA PROLONGE SA CAPACITÉ FINANCIÈRE À PLUS DE 12 MOIS
Capital/Financing Update
2026-03-09 French
TME Pharma extends financial runway to over 12 months
Capital/Financing Update
2026-03-09 English
TME PHARMA FAIT LE POINT SUR SES ACTIVITÉS
Regulatory Filings
2026-01-05 French
TME Pharma provides update on its activities
Regulatory Filings
2026-01-05 English